Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Multimodal Therapy Including Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Can Result in Long-term Disease-free Survival in Pediatric Desmoplastic Small Round Cell Tumor With Extraperitoneal Disease. J Pediatr Hematol Oncol 2020 Jun 16

Date

06/20/2020

Pubmed ID

32555030

DOI

10.1097/MPH.0000000000001861

Scopus ID

2-s2.0-85086724925

Abstract

Desmoplastic small round cell tumor is a rare sarcoma with 5-year overall survival of 15%. An 8-year-old female presented with diffuse abdominal/pelvic desmoplastic small round cell tumor including numerous liver metastasis. She underwent neoadjuvant chemotherapy followed by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Residual disease was found shortly after CRS/HIPEC which was resected, followed by whole abdomen/pelvic radiation and autologous hematopoietic cell transplant. Previous papers have reported dismal survival in patients with liver metastasis and residual disease arguing against CRS/HIPEC. Our patient remains disease-free over 6 years after completing therapy indicating long-term survival is achievable with aggressive multimodal therapy.

Author List

Xiao J, Browning MB, Boyd KP, Suchi M, Turaga KK, Firat SY, Mortland LJ, Lal DR

Authors

Meghen B. Browning MD Associate Professor in the Pediatrics department at Medical College of Wisconsin
Selim Firat MD Associate Professor in the Radiation Oncology department at Medical College of Wisconsin
Dave Lal MD, MPH Professor in the Surgery department at Medical College of Wisconsin
Mariko Suchi MD, PhD Associate Professor in the Pathology department at Medical College of Wisconsin